fda’s quality assessment and knowledge management - kasa (11of33) quality – oct. 16-17, 2019
Published 4 years ago • 3.4K plays • Length 23:35
Download video MP4
Download video MP3
Similar videos
-
16:24
fda research supporting emerging technologies with case studies (24of33) quality – oct. 16-17, 2019
-
25:06
quality assessment of blas, ndas, and andas (3of33) quality – oct. 16-17, 2019
-
26:22
application manufacturing assessment (4of33) quality – oct. 16-17, 2019
-
14:31
biosimilars and interchangeables - regulatory highlights (27of33) quality – oct. 16-17, 2019
-
20:57
quality metrics, quality culture, and data-driven decisions (16of33) quality – oct. 16-17, 2019
-
20:49
assessment of the multi-attribute method (mam) substance (23of33) quality – oct. 16-17, 2019
-
17:14
microbiology quality assessment (18of27) generic drugs forum 2018
-
27:06
mdufa iv: accessing and using real-world and postmarket data for regulatory decision-making
-
16:06
data quality expectations for biosimilars with case studies (29of33) quality – oct. 16-17, 2019
-
26:11
continuous manufacturing of drug product (20of33) quality – oct. 16-17, 2019
-
18:17
case studies: continuous manufacturing of drug substance (21of33) quality – oct. 16-17, 2019
-
22:17
pharmaceutical quality surveillance program (14of33) quality – oct. 16-17, 2019
-
16:35
application communications – quality assessment perspective
-
20:05
panel questions and discussion (6of33) quality – oct. 16-17, 2019
-
19:50
the “deemed to be a license” provision of the bpci act (31of33) quality – oct. 16-17, 2019
-
24:48
fda perspectives on biosimilar bla-manufacturing (28of33) quality – oct. 16-17, 2019
-
18:30
emerging technology program (18of33) quality – oct. 16-17, 2019
-
24:56
api facility inspections
-
20:31
fda announces quality management maturity programs
Clip.africa.com - Privacy-policy